NRX Pharmaceuticals, Inc. (NRXP) Form 424B5 — Jun 3, 2026
NRx Pharmaceuticals, Inc. (NRXP) is offering 5,714,286 shares of common stock at $3.50 per share, raising approximately $18.8 million in net proceeds. The offering is priced at a 24% discount to the last reported market price of $4.62, with BTIG and Lucid Capital Markets acting as underwriters. The filing discloses significant financial weakness, noting a negative net tangible book value of $(0.49) per share as of March 31, 2026.
Key figures
- Greenshoe
- 857142
- Net Proceeds
- 18800000.94
- Gross Proceeds
- 20000001
- Offering Price
- 3.5
- Shares Offered
- 5714286
- Shares Outstanding
- 36228993
- Last Reported Price
- 4.62
- Immediate Dilution Per Share
- 3.44
- Total Shares Outstanding With Option
- 37086135
- Pro Forma Net Tangible Book Value Per Share
- 0.06
Price after filing
1 day: 0.0%7 days: -7.2%30 days: -4.4%
Close on the filing date to close N calendar days later (from $4.05). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.